Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NEOG · against 324 other Healthcare companies of similar size
Ranked #222 of 325 · scores higher than 31% of peers
Bars: peers in each 10-point band of the growth score27 peers with a growth score of 30–39, including NEOG · Click a bar to see the companies
Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | NEOG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 324 reported | -0.3% | 7.0% | 26% | 33% | |
| Earnings per share growthHigher is better · 195 reported | Not reported | 10.0% | — | — | 33% |
| 3-year revenue growthHigher is better · 317 reported | -1.3% | 7.9% | 21% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 220 | 170.4B THB (≈$4.8B) | 37 | 70 | |
| 222 | 10.2B CNY (≈$1.4B) | 36 | 69 | |
| 222 | 16.5B CNY (≈$2.3B) | 36 | 57 | |
| 222 | 3.0B USD | 36 | 35 | |
| 222 | 2.6B USD | 36 | 32 | |
| 226 | 28.4B CNY (≈$4.0B) | 35 | 62 | |
| 226 | 263.1B JPY (≈$1.8B) | 35 | 72 | |
| 226 | 2.0B USD | 35 | 27 | |
| 229 | 10.2B CNY (≈$1.4B) | 34 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score